We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microbiome Alterations Influence Lung Disease Prognosis

By LabMedica International staff writers
Posted on 16 Oct 2018
Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD), is a group of lung diseases affecting the interstitium, which is the tissue and space around the air sacs of the lungs.

ILD involves alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues. More...
It may occur when an injury to the lungs triggers an abnormal healing response. Alterations to the respiratory microbiome have been identified as a predisposing factor of interstitial lung diseases.

Physicians at the Beaumont Health System (Royal Oak, MI, USA) and their colleagues conducted a retrospective analysis of 472 patients with ILD who were admitted to a large tertiary care academic center from January 1, 2010, to December 31, 2016. Patient data were extracted from electronic records using billing codes for various ILD. The majority of the patients had either pulmonary fibrosis or sarcoidosis.

The team collected 170 respiratory cultures were collected from the study population. The majority of the respiratory isolates were gram-negative pathogens (39% Pseudomonas and 18% other gram-negative organisms); 27% were methicillin-resistant Staphylococcus aureus (MRSA). Patients infected with gram-negative organisms (other than Pseudomonas) and MRSA had the highest 30-day mortality (39% and 32% respectively) compared with lower mortality for those infected with Pseudomonas and other gram positive organisms (7% and 14% respectively).

Patients infected with gram-negative organisms other than Pseudomonas also had higher rates of vasopressin administration compared with those infected with other organisms. Rates of intensive care units (ICU) admission also differed according to organism that was cultured. These associations persisted even after adjustment for the other variables including type of ILD, age, gender, comorbid conditions and smoking history. There was no association between the use of immunosuppressant medications or antifibrotics and the development of resistant pathogens.

Hira Iftikhar, MD, MBBS, the lead author of the study, said, “The presence of gram-negative bacteria is a risk factor for adverse events. These bacteria could lead to a higher mortality rate, ICU admission and increased vasopressor use. A larger study should be conducted to establish the risk factors for the mortality in hospitalized ILD patients including results of respiratory cultures.” The study was presented at the annual meeting of Chest, held October 6-10, 2018, in San Antonio, TX, USA.

Related Links:
Beaumont Health System


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.